Why is Welcure Drugs falling/rising?

As of 28-Oct, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 0.62, which reflects a decrease of 0.03 or 4.62%. The stock has been underperforming significantly, having fallen consecutively for the last five days, resulting in a total drop of 19.48% during this period. Additionally, it is trading below all key moving averages, indicating a bearish trend. The delivery volume has also decreased sharply, with a 77.1% drop compared to the five-day average, suggesting reduced investor participation. The stock's year-to-date performance shows a substantial decline of 40.97%, further highlighting its struggles in the market. In the broader market context, while the Sensex has gained 0.24% over the past week, Welcure Drugs has seen a much steeper decline of 16.22% in the same timeframe, indicating a significant underperformance relative to the benchmark. Over the past month, however, the stock has shown some resilience with a positive return of 13.68%, contrasting with the Sensex's 5.22% increase. This mixed performance suggests that while there may have been some recovery recently, the overall trend remains negative, particularly in light of the stock's long-term underperformance compared to the benchmark, which has risen 8.30% year-to-date.